Exploring the Latest Trends and Developments in High-Throughput Screening Market

 The global high-throughput screening (HTS) market is expected to grow at a CAGR of 11.8% during the forecast period. The growth of this market is driven by increasing R&D spending in the HTS market. Increased R&D spending can serve as a driving force for the HTS market due to expanded drug discovery efforts, a focus on personalized medicine, technological advancements, and collaborative research efforts.

The report High-Throughput Screening Market is projected to reach USD 50.2 billion by 2029 from USD 28.8 billion in 2024, at a CAGR of 11.8% during the forecast period of 2024 to 2029.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950

Key Market Drivers: -

 

                   1.1 Growing adoption of open innovation models in pharmaceutical & biotechnology companies

                   1.2 Government funding and venture capital investments

                   1.3 Increasing R&D spending

                   1.4 Technological advancements

 

Market Segmentation: -

On the basis type of product & service, the high-throughput screening market is broadly segmented into consumables, instruments, services, and software. In 2023, consumables accounted for the largest share of the high-throughput screening market. This can primarily be attributed to the wide use of reagents & assay kits in HTS techniques, increasing pharmaceutical R&D, and rising government funding for life sciences research.

Based on application, the high-throughput screening market is categorized into drug discovery, biochemical screening, life sciences research, and other applications. The drug discovery application segment accounted for the largest share of the high-throughput screening market in 2022. The key factor driving this segment's growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure.

Regional Analysis: -

Geographically, the high-throughput screening market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In 2022, North America accounted for the largest share of the high-throughput screening market, followed by Europe and Asia Pacific. The large share of North America in the global market is attributed to the increasing prevalence of diseases, rising pharmaceutical R&D expenditure, and the presence of major players in the region are factors driving the growth of the HTS market in this region.

Market Opportunity: -

Emerging markets like China, India, and Brazil have experienced rapid expansion in the life science and biotechnology sectors in recent years. These regions have a significant pool of talented researchers, physicians, and scientists who are actively pursuing research in these fields. Additionally, government initiatives in emerging markets play a crucial role in promoting the adoption and development of HTS technologies. Governments can establish regulatory frameworks and guidelines to ensure the safe and ethical use of HTS technologies.

Recent Developments of High Throughput Screening Industry

·         In October 2023, Revvity Inc. (US), collaborated with SCIEX, a subsidiary of Danaher Corporation (US), to develop mass spectrometry solutions for newborn screening.

·         In May 2024, Bio-Rad Laboratories, Inc. (US) launched three new StarBright Red Dyes—StarBright Red 715, 775, and 815—providing greater choice and flexibility in conventional and full-spectrum multicolor flow cytometry panels.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=134981950

Top Key Players: -

Key players in the high-throughput screening (HTS) market include Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Trading AG (Switzerland), AXXAM S.p.A (Italy), Promega Corporation (US), Bio-Rad Laboratories, Inc.(US), Promega Corporation (US), Hamilton Company (US), Corning Incorporated (US), Charles River Laboratories (US), Lonza (Switzerland), REPROCELL Inc. (Japan), Aurora Biomed (Canada), BMG LABTECH (Germany), DIANA Biotechnologies, s.r.o. (Czech Republic), NanoTemper Technologies GmbH (Germany), Creative Biolabs (US), Biomat Srl (Italy), HighRes Biosolutions (US), Cyclica Inc. (Canada), Crown Bioscience (US), and Sygnature Discovery (UK).

 

Related News: -

https://www.prnewswire.com/news-releases/global-high-throughput-screening-hts-market-to-reach-usd-50-2-billion-by-2029-opportunities-challenges-and-growth-drivers--marketsandmarkets-302195653.html

 

Exploring the Latest Trends and Developments in High-Throughput Screening Market

 The global high-throughput screening (HTS) market is expected to grow at a CAGR of 11.6% during the forecast period. The growth of this market is driven by increasing R&D spending in the HTS market. Increased R&D spending can serve as a driving force for the HTS market due to expanded drug discovery efforts, a focus on personalized medicine, technological advancements, and collaborative research efforts.

The report High-Throughput Screening (HTS) Market  is projected to reach USD 44.5 billion by 2028 from USD 25.7 billion in 2023, at a CAGR of 11.6% during the forecast period of 2023 to 2028.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950

Key Market Drivers: -

 

                   1.1 Growing adoption of open innovation models in pharmaceutical & biotechnology companies

                   1.2 Government funding and venture capital investments

                   1.3 Increasing R&D spending

                   1.4 Technological advancements

 

Market Segmentation: -

On the basis type of product & service, the high-throughput screening market is broadly segmented into consumables, instruments, services, and software. In 2022, consumables accounted for the largest share of the high-throughput screening market. This can primarily be attributed to the wide use of reagents & assay kits in HTS techniques, increasing pharmaceutical R&D, and rising government funding for life sciences research.

Based on application, the high-throughput screening market is categorized into drug discovery, biochemical screening, life sciences research, and other applications. The drug discovery application segment accounted for the largest share of the high-throughput screening market in 2022. The key factor driving this segment's growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure.

Regional Analysis: -

Geographically, the high-throughput screening market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In 2022, North America accounted for the largest share of the high-throughput screening market, followed by Europe and Asia Pacific. The large share of North America in the global market is attributed to the increasing prevalence of diseases, rising pharmaceutical R&D expenditure, and the presence of major players in the region are factors driving the growth of the HTS market in this region.

Market Opportunity: -

Emerging markets like China, India, and Brazil have experienced rapid expansion in the life science and biotechnology sectors in recent years. These regions have a significant pool of talented researchers, physicians, and scientists who are actively pursuing research in these fields. Additionally, government initiatives in emerging markets play a crucial role in promoting the adoption and development of HTS technologies. Governments can establish regulatory frameworks and guidelines to ensure the safe and ethical use of HTS technologies.

Recent Developments of High Throughput Screening Industry

• In February 2023, Agilent Technologies, Inc. launched the on-deck thermal cycler that integrates with the Agilent Bravo NGS automated liquid handling platform.
• In February 2023, PerkinElmer Inc. launched the Multimode Plate Reader for high-throughput screening (HTS) applications and to accelerate drug discovery efforts.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=134981950

Top Key Players: -

Key players in the high-throughput screening (HTS) market include Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Trading AG (Switzerland), AXXAM S.p.A (Italy), Promega Corporation (US), Bio-Rad Laboratories, Inc.(US), Promega Corporation (US), Hamilton Company (US), Corning Incorporated (US), Charles River Laboratories (US), Lonza (Switzerland), REPROCELL Inc. (Japan), Aurora Biomed (Canada), BMG LABTECH (Germany), DIANA Biotechnologies, s.r.o. (Czech Republic), NanoTemper Technologies GmbH (Germany), Creative Biolabs (US), Biomat Srl (Italy), HighRes Biosolutions (US), Cyclica Inc. (Canada), Crown Bioscience (US), and Sygnature Discovery (UK).

 

Related News: -

https://www.prnewswire.com/news-releases/high-throughput-screening-hts-market-worth-44-5-billion--marketsandmarkets-301870067.html

 

            

The Impact of High-Throughput Screening on Biotechnology and Pharmaceutical Industries

 Introduction

The high-throughput screening market refers to the industry involved in the development and commercialization of technologies, instruments, and services for the high-throughput screening of compounds in drug discovery and other life science research applications. High-throughput screening is a process that enables the rapid and automated testing of large numbers of chemical or biological compounds for their ability to interact with biological targets of interest, such as enzymes, receptors, or DNA.

Global High-Throughput Screening Market Overview

The global high-throughput screening (HTS) market size is projected to reach USD 26.4 billion by 2025 from USD 15.3 billion in 2020, at a CAGR of 11.5% during the forecast period.

The high-throughput screening (HTS) market growth is driven mainly by factors such as increasing R&D spending by pharmaceutical & biotechnology companies, technological advancements in high-throughput screening market and the availability of government funding & venture capital investments. Emerging markets and growing applications in life sciences research are also factors expected to provide growth opportunities for players in the market.

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950

MARKET DRIVERS

·         The growing adoption of open innovation models in pharmaceutical & biotechnology companies

·         Government funding and venture capital investments

·         Increasing R&D spending  

·         Technological advancements in the HTS market

MARKET RESTRAINTS

·         The capital-intensive nature of HTS instruments

·         Complexities in assay development

MARKET OPPORTUNITIES

·         Emerging markets

·         Growing applications in stem cell research

MARKET CHALLENGES

·         The dearth of skilled operators

Market Segmentation:

On the basis type of product & service, the HTS Market is broadly segmented into consumables , instruments, services, and software. In 2019, consumables accounted for the largest share of the high-throughput screening (HTS) market. This can primarily be attributed to the wide use of reagents & assay kits in HTS techniques, increasing pharmaceutical R&D, and rising government funding for life sciences research.

Based on application, the HTS Market is categorized into four segments—drug discovery, biochemical screening, life sciences, and other applications. The drug discovery application segment accounted for the largest share of the market in 2019. The key factor driving this segments growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure.

Regional Analysis:

In 2019, Asia Pacific region accounted for the fastest-growing region of the HTS Market. It is also estimated to grow at the highest CAGR in the market during the forecast period, this is mainly due to factors such as the rising R&D spending, growing public-private partnerships, and increasing government funding are factors driving the growth of the market in this region.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=134981950

Recent Developments

·         In 2020, Danaher Corporation (US) acquired the biopharma business of General Electric Company (Cytiva) to expand its presence in the high-throughput screening market.

·         In 2019, Agilent Technologies, Inc. (US) acquired BioTek Instruments (US) to expand its presence and expertise in cell analysis. This development also strengthened the firm’s position in the expansive immune-oncology and immunotherapy areas.

·         In 2019, Danaher Corporation (US) acquired Labcyte Inc. (US) to expand its liquid handling and laboratory automation business, thereby strengthening its presence in the high-throughput screening market.

Top Key Players: -

Some of the prominent players in the high-throughput screening market are Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Group Ltd. (Switzerland), AXXAM S.p.A. (Italy), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Corning Incorporated (US), and Eurofins Scientific (Luxembourg).

Conclusion:

In conclusion, the high-throughput screening market has grown significantly in recent years, driven by the increasing demand for more efficient and cost-effective drug discovery methods. High-throughput screening technologies enable researchers to quickly and accurately test large numbers of compounds for their efficacy, toxicity, and other characteristics, which can accelerate the drug development process and improve the chances of success in clinical trials. Advances in automation, robotics, and data analysis have further improved the speed and accuracy of high-throughput screening, making it an essential tool in modern drug discovery. With continued investment and innovation, the high-throughput screening market is expected to grow further, enabling the development of new and more effective treatments for a wide range of diseases.

 

 

Which product & service segment dominates in the High-throughput screening market?

 The high-throughput screening (HTS) market growth is driven mainly by factors such as increasing R&D spending by pharmaceutical & biotechnology companies, technological advancements in high-throughput screening market and the availability of government funding & venture capital investments. Emerging markets and growing applications in life sciences research are also factors expected to provide growth opportunities for players in the market.

The global high-throughput screening (HTS) market size is projected to reach USD 26.4 billion by 2025 from USD 15.3 billion in 2020, at a CAGR of 11.5% during the forecast period.

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950

MARKET DRIVERS

·         The growing adoption of open innovation models in pharmaceutical & biotechnology companies

·         Government funding and venture capital investments

·         Increasing R&D spending  

·         Technological advancements in the HTS market

MARKET RESTRAINTS

·         The capital-intensive nature of HTS instruments

·         Complexities in assay development

MARKET OPPORTUNITIES

·         Emerging markets

·         Growing applications in stem cell research

MARKET CHALLENGES

·         The dearth of skilled operators

Market Segmentation:

On the basis type of product & service, the HTS Market is broadly segmented into consumables , instruments, services, and software. In 2019, consumables accounted for the largest share of the high-throughput screening (HTS) market. This can primarily be attributed to the wide use of reagents & assay kits in HTS techniques, increasing pharmaceutical R&D, and rising government funding for life sciences research.

Based on application, the HTS Market is categorized into four segments—drug discovery, biochemical screening, life sciences, and other applications. The drug discovery application segment accounted for the largest share of the market in 2019. The key factor driving this segments growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure.

Regional Analysis:

In 2019, Asia Pacific region accounted for the fastest-growing region of the HTS Market. It is also estimated to grow at the highest CAGR in the market during the forecast period, this is mainly due to factors such as the rising R&D spending, growing public-private partnerships, and increasing government funding are factors driving the growth of the market in this region.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=134981950

Top Key Players:-

Some of the prominent players in the high-throughput screening market are Thermo Fisher Scientific Inc. (US),  Agilent Technologies, Inc. (US), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Group Ltd. (Switzerland), AXXAM S.p.A. (Italy), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Corning Incorporated (US), and Eurofins Scientific (Luxembourg).

 

High-Throughput Screening Market worth $26.4 billion by 2025 - Exclusive Report by MarketsandMarkets™

 The high-throughput screening (HTS) market growth is driven mainly by factors such as increasing R&D spending by pharmaceutical & biotechnology companies, technological advancements in high-throughput screening market and the availability of government funding & venture capital investments. Emerging markets and growing applications in life sciences research are also factors expected to provide growth opportunities for players in the market.

The global high-throughput screening (HTS) market size is projected to reach USD 26.4 billion by 2025 from USD 15.3 billion in 2020, at a CAGR of 11.5% during the forecast period.

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950

Scope of the Report

This report categorizes the high-throughput screening market into the following segments and subsegments:

High-throughput screening Market, by Product & Service

• Consumables
• Reagents & Assay Kits
• ;Laboratory Equipment
• Instruments
• Liquid Handling Systems
• Detection Systems
• Other Instruments
• Services
• Software

High-throughput Screening Market, by Technology

• Cell-based Assays
•  2D Cell Culture
• 3D Cell Culture
• Scaffold-based Technology
• Hydrogels
• Animal-derived Hydrogels
• Matrigel
• Collagen
• Synthetic Hydrogels
• Alginate/Agarose
• Inert Matrix/Solid Scaffolds
• Micropatterned Surfaces
• Scaffold-free Technology
• Ultra-low Binding Plates   
• Hanging-drop Plates
• Other Scaffold-free Technologies
• Reporter-based Assays
• Perfusion Cell Culture
• Lab-on-a-Chip Technology (LOC)
• Label-free Technology

High-throughput Screening Market, by Application

• Drug Discovery
• Biochemical Screening
• Life Sciences Research
• Other Applications

High-throughput Screning Market, by End User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Other End Users

High-throughput Screning Market, by Region

• North America
• US
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe (RoE)
• Asia Pacific (APAC)
• Japan
• China
• India
• Australia
• Rest of Asia Pacific (RoAPAC)
• Rest of the World (RoW)
• Latin America
• Middle East and Africa

Market Segmentation:

On the basis type of product & service, the HTS Market is broadly segmented into consumables , instruments, services, and software. In 2019, consumables accounted for the largest share of the high-throughput screening (HTS) market. This can primarily be attributed to the wide use of reagents & assay kits in HTS techniques, increasing pharmaceutical R&D, and rising government funding for life sciences research.

Based on application, the HTS Market is categorized into four segments—drug discovery, biochemical screening, life sciences, and other applications. The drug discovery application segment accounted for the largest share of the market in 2019. The key factor driving this segments growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure.

Regional Analysis:

In 2019, Asia Pacific region accounted for the fastest-growing region of the HTS Market. It is also estimated to grow at the highest CAGR in the market during the forecast period, this is mainly due to factors such as the rising R&D spending, growing public-private partnerships, and increasing government funding are factors driving the growth of the market in this region.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=134981950

Top Key Players:-

Some of the prominent players in the high-throughput screening market are Thermo Fisher Scientific Inc. (US),  Agilent Technologies, Inc. (US), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Group Ltd. (Switzerland), AXXAM S.p.A. (Italy), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Corning Incorporated (US), and Eurofins Scientific (Luxembourg).